Home / Brands / Zyvex / Zyvex Pharmaceuticals Cardarine - GW-501516 20 mg Research Pack

Zyvex Pharmaceuticals

Zyvex Pharmaceuticals Cardarine - GW-501516 20 mg Research Pack

Name: Zyvex Pharmaceuticals Cardarine - GW-501516 20 mg Research Pack
Brand: Zyvex Pharmaceuticals
SKU: OFFER-8509
Availability: OutOfStock

Oral · 20 mg/tab · 100 tabs

Out of stock

Zyvex Pharmaceuticals Cardarine is GW-501516, a PPAR-delta agonist supplied as 20 mg research material and not a SARM, despite the category it is shelved in. The fact file records no established half-life and a 40 day urinary metabolite tail. Available as Cardarine - GW-501516 20 mg.

GMP-manufactured, HPLC-verified, COA on file. International shipping, 4 to 10 days transit.

Discreet plain packaging

Worldwide reship guarantee

Crypto & card accepted

Product overview

Zyvex Pharmaceuticals Cardarine GW-501516 20 mg - Research Compound

Zyvex Pharmaceuticals Cardarine is GW-501516, a PPAR-delta agonist supplied here as 20 mg research material. The fact file for this card is blunt about two things: this is not a SARM and not a steroid, even though shops shelve it with the modulators, and no half-life figure is established in the cited sources at all. The compound was dropped from development in 2007 after carcinogenicity in rodents and was added to the WADA list in 2009.

100 tablets of cardarine at 20 mg per tablet
GMP-manufactured - pharmaceutical-grade production standards
HPLC-verified - independent lab testing with COA per batch
international shipping with a 4 to 10 day transit window

How Cardarine Works

GW-501516 activates the PPAR-delta receptor, a nuclear receptor involved in fatty-acid oxidation and energy metabolism, which is a completely different pathway from the androgen receptor used by the modulators. That is why it is grouped in the catalogue for convenience but read separately in the laboratory. The direct comparisons remain Zyvex Ostarine - MK-2866, Zyvex Ligandrol - LGD-4033 and Zyvex Testolone - RAD-140.

Detection & Safety History

The checked file records that sulfone metabolites remain detectable in urine for up to 40 days after a single dose, while the parent drug clears in no more than five days. WADA listed the compound in 2009 in class S4, hormone and metabolic modulators, with explicit warnings that it is not safe, and the carcinogenicity finding in rodents is why development stopped. No hepatotoxicity data was found, so no liver rating is assigned.

Quality & Authenticity

Each batch is produced under GMP conditions and verified by HPLC, with the Certificate of Analysis held for the lot. Keep the pack sealed, dry and away from light. Buy cardarine here as research material only; it is not and never was an approved medicine.

For laboratory research only. Consult a healthcare professional before use.

Specifications

Brand	Zyvex Pharmaceuticals
Active Substance	Cardarine, GW-501516
Dosage	20 mg option
Package	100 tablets per pack
Form	Oral tablets, 20 mg per tablet
Drug Class	PPAR-delta agonist, not a SARM
Manufacturing	GMP-certified
Testing	HPLC per batch, COA on file
Shipping	International, 4-10 days transit

Stacks

Cardarine Is Not A SARM

Shops group this compound with the receptor modulators, but the laboratory reading is different: Zyvex Ostarine acts at the androgen receptor, while GW-501516 acts at a nuclear receptor that handles fatty-acid oxidation.

Outcome: no shared endpoint between the two, so results cannot be pooled.

Note: both are prohibited in sport, under different WADA classes.

Planning Around A 40 Day Tail

Any study that collects urine samples has to account for the sulfone metabolites remaining detectable for up to 40 days after one dose, which is eight times longer than the parent compound survives.

Outcome: the sampling schedule, not the half-life, is the limiting factor in this design.

FAQ

Before you ask

Questions, answered

No, and the fact file for this card says so explicitly. GW-501516 is a PPAR-delta agonist, a metabolic modulator, and neither a SARM nor a steroid, even though it is shelved with the modulators because that is where buyers look for it. The receptor it activates controls fatty-acid oxidation rather than androgen signalling, so it belongs to a different family with different research endpoints.

Not established in the sources checked for this card, and no figure is invented here. What the file does record is detection behaviour: the parent drug is measurable in urine for no more than five days, while sulfone metabolites persist for up to 40 days after a single dose. That contrast matters far more for research design than a half-life that nobody has published.

The safety history is the headline: development stopped in 2007 because of carcinogenicity in rodents, and WADA added the compound in 2009 with explicit warnings that it is not safe. The checked file found no confirmed hepatotoxicity data, so no liver rating is assigned, but the cancer finding in animals is a documented concern rather than an internet rumour, and questions belong with a clinician.

Yes. The fact file records that WADA listed GW-501516 in 2009 in class S4, hormone and metabolic modulators, and the agency issued extra warnings about the compound rather than a routine listing. That prohibition has a separate basis from the receptor modulator class, even though the outcome for a tested athlete is the same.

The 20 mg option is listed on this page as research material, with the pack selected above. At the last check the 100 tablet pack was out of stock and no price was printed for the offer, and international shipping is listed at 45.00 USD with a four to ten day transit window.

No reviews yet

Be the first to share your experience with Zyvex Pharmaceuticals Cardarine - GW-501516 20 mg Research Pack

Complete the cycle